Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT-334441 with cardiovascular drugs in healthy subjects
NCT02479204Phase 1Terminated
- Sponsor
- Viatris
- Start
- Apr 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cenerimod (4 arms), sponsored by Viatris. Primary endpoints: PR interval measured by 12-lead ECG at Day 16, Heart rate measured by 12-lead ECG at Day 16 and 1 more. Started Apr 2015; status: terminated.
02
Drugs
cenerimod
Beyond the preview
Go deeper on NCT02479204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02479204.